Engerix B Vaccine
Engerix B Vaccine, bioengineered and grown in yeast, for intramuscular injection to protect against Hepatitis B, by SmithKline Beecham Pharmaceuticals, Welwyn Garden City, England, 1993
- Object Number:
- 1994-139 Pt1
- type:
- vaccines
Box containing ten disposable syringes, each prefilled with 1ml of Engerix B Vaccine, bioengineered and grown in yeast, for intramuscular injection to protect against Hepatitis B, by SmithKline Beecham Pharmaceuticals, Welwyn Garden City, England, 1993Engerix B Vaccine, bioengineered and grown in yeast, for intramuscular injection to protect against Hepatitis B, by SmithKline Beecham Pharmaceuticals, Welwyn Garden City, England, 1993
Details
- Category:
- Public Health & Hygiene
- Object Number:
- 1994-139
- type:
- vaccine
- credit:
- SmithKline Beecham Pharmaceuticals
Parts
Ten disposable vaccination syringes to protect against hepatitis B, Belgium, 1993
Box containing ten disposable syringes, each prefilled with 1ml of Engerix B Vaccine, bioengineered and grown in yeast, for intramuscular injection to protect against Hepatitis B, by SmithKline Beecham Pharmaceuticals, Welwyn Garden City, England, 1993
More
Hepatitis B is a disease that causes inflammation of the liver. Long term effects include liver diseases and liver cancer. The vaccine was introduced in the 1980s. It is thought that immunity from vaccination is for life, although this has not been confirmed. ‘Engerix B’ was the first commercially made and sold bio-engineered vaccine. Made by SmithKline Beecham Pharmaceuticals, the vaccine was grown in yeast.
- Materials:
- plastic (unidentified) , metal (unknown) , paper (fibre product) and cardboard
- Object Number:
- 1994-139 Pt2
- Image ©
- The Board of Trustees of the Science Museum
Cardboard Box for Syringes containing Engerix B Vaccine
Cardboard box for Engerix B vaccines, SmithKline Beecham Pharmaceuticals, Welwyn Garden City, England, 1993, white with blue header.
More
Hepatitis B is a disease that causes inflammation of the liver. Long term effects include liver diseases and liver cancer. The vaccine was introduced in the 1980s. It is thought that immunity from vaccination is for life, although this has not been confirmed. ‘Engerix B’ was the first commercially made and sold bio-engineered vaccine. Made by SmithKline Beecham Pharmaceuticals, the vaccine was grown in yeast.
